医学分子生物学杂志 ›› 2022, Vol. 19 ›› Issue (3): 200-205.doi: 10.3870/j.issn.1672-8009.2022.03.004

• 论著 • 上一篇    下一篇

miR-142-5p 靶向 MCL-1 对胆管癌细胞上皮-间质转化及吉西他滨 化疗敏感性的影响 

  

  1. 1咸阳市中心医院肝胆二科 陕西省咸阳市, 712000  2西安交通大学第一附属医院肝胆外科 西安市, 710061
  • 出版日期:2022-05-31 发布日期:2022-06-17
  • 基金资助:
    陕西省重点研发计划 (No. 2020SF-060)

Effect of mir-142-5p on Epithelial-mesenchymal Transition and Gemcitabine Chemosensitivity of Cholangiocarcinoma Cells by Targeting MCL-1 

  1. 1 The Second Department of Hepatobiliary Surgery, Xianyang Central Hospital, Xianyang, Shaanxi, 712000, China  2 Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’ an, 710061, China 
  • Online:2022-05-31 Published:2022-06-17

摘要: 目的 探讨 miR-142-5p 靶向髓细胞白血病因子 1 (myeloid cell leukemin-1, MCL-1) 对人胆管癌 细胞 QBC939 上皮间质化 (epithelial-mesenchymal transition, EMT) 及吉西他滨 (Gemcitabine, GEM) 化疗 敏感性的影响。 方法 体外培养胆管癌细胞 QBC939 及人正常胆管上皮细胞 HIBEC, 随机分为对照组、 miR-142-5p 阴性对照 (NC) 组和 miR-142-5p 模拟物 (mimics) 组。 实时荧光定量 PCR (RT-qPCR) 法检 测各组 QBC939 细胞和 HIBEC 细胞中 miR-142-5p 和 MCL-1 mRNA 表达情况; 划痕实验和 Transwell 实验分别 检测各组 QBC939 细胞迁移和侵袭变化情况; 蛋白印迹分析法检测各组 QBC939 细胞上皮型钙黏蛋白 (E-cadherin)、 神经性钙黏附蛋白 (N-cadherin) 和波形蛋白 (Vimentin) 表达变化; 双荧光素酶报告实验验证 miR-142-5p 与 MCL-1 的靶向关系; 使用浓度为 0. 625 μg / mL GEM 处理转染 miR-142-5p 后的 QBC939 细胞, 同时设置对照组, MTT 检测细胞增殖, Annexin V-FITC/ PI 试剂盒检测细胞凋亡。 结果 与人正常胆管细胞 HIBEC 相比, 胆管癌细胞 QBC939 中 miR-142-5p 呈低表达, MCL-1 mRNA 呈高表达。 经 Targetscan Human 数据库预测显示, miR-142-5p 与 MCL-1 mRNA 3′UTR 区有结合位点。 与 MCL-1-3′UTR-WT + miR-142-5p NC 组比较, MCL-1-3′UTR-WT + miR-142-5p mimics 组荧光素酶活性降低 (P< 0. 05)。 与对照组和 miR-142-5p NC 组相比, miR-142-5p mimics 组 QBC939 细胞 miR-142-5p 表达水平、 E-cadherin 蛋白表达水平显著升高 (P< 0. 05), MCL-1 mRNA 和蛋白表达、 N-cadherin、 Vimentin 蛋白表达水平显著降低 (P< 0. 05), 细胞迁 移、 侵袭能力显著减弱 (P< 0. 05); 与 miR-142-5p NC + GEM 组相比, miR-142-5p mimics + GEM 组 QBC939 细胞存活率显著降低, 凋亡率增加 (P< 0. 05)。 结论 过表达 miR-142-5p 可通过靶向抑制 MCL-1 表达从而 抑制人胆管癌细胞的 EMT、 增加胆管癌细胞对 GEM 的化疗敏感性。 

关键词: miR-142-5p, 髓细胞白血病因子 1, 胆管癌细胞, 上皮间质转化 

Abstract: Objective To investigate the effect of miR-142-5p on epithelial-mesenchymal transition (EMT) and chemosensitivity of gemcitabine (GEM) in human cholangiocarcinoma cell line QBC939 by targeting myeloid cell leukemin-1 ( MCL-1 ). Methods Human cholangiocarcinoma cell line QBC939 and human normal bile duct epithelial cell line HIBEC were cultured in vitro and then randomly divided into control group, miR-142-5p negative control (NC) group and miR-142- 5p mimics group. The mRNA expression levels of miR-142-5p and MCL-1 in QBC939 cells and HIBEC cells were detected by real-time quantitative PCR (RT-qPCR); the migration and invasion of QBC939 cells were determined by wound healing assay and transwell assay; Western blotting was used to detect the expression level of E-cadherin, N-cadherin and Vimentin in QBC939 cells; dualluciferase assay was used to verify the relationship between miR-142-5p and MCL-1; QBC939 cells transfected with miR-142-5p were treated with GEM at a concentration of 0. 625 μg / mL. The viability and apoptosis of QBC939 cells were measured by MTT assay and Annexin V-FITC / PI kit respectively. Results The expression level of miR-142-5p was lower and the expression level of MCL-1 was higher in cholangiocarcinoma QBC939 cells than in human normal bile duct HIBEC cells. According to the prediction of TargetScan Human Database, there was a binding site for miR-142-5p on the 3′UTR region of MCL-1 mRNA. Compared with MCL-1-3′UTR-WT + miR-142-5p NC group, the luciferase activity of MCL-1-3′UTR-WT + miR-142-5p mimics group was significantly decreased (P< 0. 05). The expression level of miR-142-5p and E-cadherin were significantly increased (P< 0. 05), the expression level of MCL-1, N-cadherin and vimentin were significantly decreased (P< 0. 05), and the number of migratory and invasive cells were profoundly reduced in miR-142-5p mimics group compared with control group and miR-142-5p NC group (P < 0. 05 for all). The survival rate of QBC939 cells in miR-142-5p mimics + GEM group was significantly lower and the apoptosis rate was higher than that in miR-142-5p NC + GEM group (P < 0. 05). Conclusion Overexpression of miR-142-5p can inhibit the EMT of and increase the chemosensitivity of GEM to cholangiocarcinoma cells by targeting MCL-1.

Key words: miR-142-5p, myeloid cell leukemin-1, cholangiocarcinoma cells, epithelial-mesenchymal transition

中图分类号: